Literature DB >> 21825133

Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase.

Janine Schmid1, Barbara Ludwig, Andrew V Schally, Anja Steffen, Christian G Ziegler, Norman L Block, Yassemi Koutmani, Mathias D Brendel, Katia P Karalis, Charmaine J Simeonovic, Julio Licinio, Monika Ehrhart-Bornstein, Stefan R Bornstein.   

Abstract

Corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone (GHRH), primarily characterized as neuroregulators of the hypothalamic-pituitary-adrenal axis, directly influence tissue-specific receptor-systems for CRH and GHRH in the endocrine pancreas. Here, we demonstrate the expression of mRNA for CRH and CRH-receptor type 1 (CRHR1) and of protein for CRHR1 in rat and human pancreatic islets and rat insulinoma cells. Activation of CRHR1 and GHRH-receptor significantly increased cell proliferation and reduced cell apoptosis. CRH stimulated both cellular content and release of insulin in rat islet and insulinoma cells. At the ultrastructural level, CRHR1 stimulation revealed a more active metabolic state with enlarged mitochondria. Moreover, glucocorticoids that promote glucose production are balanced by both 11b-hydroxysteroid dehydrogenase (11β-HSD) isoforms; 11β-HSD-type-1 and 11β-HSD-type-2. We demonstrated expression of mRNA for 11β-HSD-1 and 11β-HSD-2 and protein for 11β-HSD-1 in rat and human pancreatic islets and insulinoma cells. Quantitative real-time PCR revealed that stimulation of CRHR1 and GHRH-receptor affects the metabolism of insulinoma cells by down-regulating 11β-HSD-1 and up-regulating 11β-HSD-2. The 11β-HSD enzyme activity was analyzed by measuring the production of cortisol from cortisone. Similarly, activation of CRHR1 resulted in reduced cortisol levels, indicating either decreased 11β-HSD-1 enzyme activity or increased 11β-HSD-2 enzyme activity; thus, activation of CRHR1 alters the glucocorticoid balance toward the inactive form. These data indicate that functional receptor systems for hypothalamic-releasing hormone agonists exist within the endocrine pancreas and influence synthesis of insulin and the pancreatic glucocorticoid shuttle. Agonists of CRHR1 and GHRH-receptor, therefore, may play an important role as novel therapeutic tools in the treatment of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825133      PMCID: PMC3158163          DOI: 10.1073/pnas.1110965108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.

Authors:  Sun Shin Yi; In Koo Hwang; Jae Hoon Shin; Jung Hoon Choi; Choong Hyun Lee; Il Yong Kim; Yo Na Kim; Moo-Ho Won; In-Sun Park; Je Kyung Seong; Yeo Sung Yoon
Journal:  J Chem Neuroanat       Date:  2010-05-21       Impact factor: 3.052

2.  Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets.

Authors:  Barbara Ludwig; Christian G Ziegler; Andrew V Schally; Claudius Richter; Anja Steffen; Normund Jabs; Richard H Funk; Mathias D Brendel; Norman L Block; Monika Ehrhart-Bornstein; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 3.  11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus.

Authors:  G Hollis; R Huber
Journal:  Diabetes Obes Metab       Date:  2011-01       Impact factor: 6.577

Review 4.  11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes.

Authors:  Stuart A Morgan; Jeremy W Tomlinson
Journal:  Expert Opin Investig Drugs       Date:  2010-09       Impact factor: 6.206

5.  Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets.

Authors:  M O Huising; A P Pilbrow; M Matsumoto; T van der Meulen; H Park; J M Vaughan; S Lee; W W Vale
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

6.  Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.

Authors:  K Krause; A Schnitger; S Fimmel; E Glass; C C Zouboulis
Journal:  Horm Metab Res       Date:  2007-02       Impact factor: 2.936

7.  Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men.

Authors:  Daniël H van Raalte; Valentina Nofrate; Mathijs C Bunck; Thijs van Iersel; Jeroen Elassaiss Schaap; Ulla K Nässander; Robert J Heine; Andrea Mari; Wim H A Dokter; Michaela Diamant
Journal:  Eur J Endocrinol       Date:  2010-02-02       Impact factor: 6.664

Review 8.  11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.

Authors:  R Ge; Y Huang; G Liang; X Li
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

9.  CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner.

Authors:  Mark O Huising; Talitha van der Meulen; Joan M Vaughan; Masahito Matsumoto; Cynthia J Donaldson; Hannah Park; Nils Billestrup; Wylie W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.

Authors:  Kazunori Kageyama; Ryoichi Kimura; Sechiko Suga; Yoshiji Ogawa; Toshihiro Suda; Makoto Wakui
Journal:  Peptides       Date:  2006-02-28       Impact factor: 3.750

View more
  21 in total

1.  Is 11β-HSD1 expressed in islet β-cells and regulated by corticotropin-releasing hormone?

Authors:  Jun-Li Liu; Coimbatore B Srikant; Subrata Chowdhury
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-09       Impact factor: 11.205

2.  Relationships of hardiness to physical and mental health status in military men: a test of mediated effects.

Authors:  Marcus K Taylor; Ricardo Pietrobon; John Taverniers; Matthew R Leon; Benedict J Fern
Journal:  J Behav Med       Date:  2011-11-23

Review 3.  Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes: Systematic review.

Authors:  Elina Tsiouli; Evangelos C Alexopoulos; Charikleia Stefanaki; Christina Darviri; George P Chrousos
Journal:  Can Fam Physician       Date:  2013-02       Impact factor: 3.275

Review 4.  Survival of encapsulated islets: More than a membrane story.

Authors:  Uriel Barkai; Avi Rotem; Paul de Vos
Journal:  World J Transplant       Date:  2016-03-24

5.  SurfaceGenie: a web-based application for prioritizing cell-type-specific marker candidates.

Authors:  Matthew Waas; Shana T Snarrenberg; Jack Littrell; Rachel A Jones Lipinski; Polly A Hansen; John A Corbett; Rebekah L Gundry
Journal:  Bioinformatics       Date:  2020-06-01       Impact factor: 6.937

6.  11β-HSD1 modulates LPS-induced innate immune responses in adipocytes by altering expression of PTEN.

Authors:  Wenfang Lai; Xue Tian; Qing Xiang; Kedan Chu; Yicong Wei; Jingti Deng; Shaoping Zhang; John Brown; Guizhu Hong
Journal:  Mol Endocrinol       Date:  2015-03-03

7.  Fetal programming of children's obesity risk.

Authors:  Stephanie A Stout; Emma V Espel; Curt A Sandman; Laura M Glynn; Elysia Poggi Davis
Journal:  Psychoneuroendocrinology       Date:  2014-12-17       Impact factor: 4.905

8.  CRFR1 activation protects against cytokine-induced β-cell death.

Authors:  Lykke Blaabjerg; Gitte L Christensen; Masahito Matsumoto; Talitha van der Meulen; Mark O Huising; Nils Billestrup; Wylie W Vale
Journal:  J Mol Endocrinol       Date:  2014-10-16       Impact factor: 5.098

9.  Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone.

Authors:  Undine Schubert; Janine Schmid; Susann Lehmann; Xian Y Zhang; Henning Morawietz; Norman L Block; Waldemar Kanczkowski; Andrew V Schally; Stefan R Bornstein; Barbara Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

10.  Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.

Authors:  Renzhi Cai; Andrew V Schally; Tengjiao Cui; Luca Szalontay; Gabor Halmos; Wei Sha; Magdolna Kovacs; Miklos Jaszberenyi; Jinlin He; Ferenc G Rick; Petra Popovics; Rosemeire Kanashiro-Takeuchi; Joshua M Hare; Norman L Block; Marta Zarandi
Journal:  Peptides       Date:  2013-12-25       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.